SMi is proud to present the New Ophthalmic Drugs Focus Day  - Novel Drug Delivery Through a Complex Barrier

Introducing the only ophthalmic conference to hold a full day exploring alternatives to intravitreal delivery to the posterior segment of the eye. With the global ophthalmic drug market currently valued at $17,364 million USD, this focus day will asses the growing need for research and development of novel delivery approaches to expand the current ophthalmic delivery methods in today's market.

In conjunction with Europe’s leading Ophthalmic Drugs conference, we will explore new discoveries in novel drug delivery through case studies, regulatory outlooks and industry examples to give a comprehensive overview of the Ophthalmic Drug Delivery space.

This focus day offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more.

We look forward to welcoming you to the conference in November.